It is recommended that patients with methemoglobin levels >30%, high risk factors such as anemia, or symptoms at any level should be treated using methylene blue at a dose of 1-2 mg/kg body weight intravenously over 5 min. Here, HBG2 is linked to anemia (phenotype).